Citigroup’s Vor Biopharma VOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $142K | Buy |
+87,485
| New | +$142K | ﹤0.01% | 3517 |
|
|
2025
Q1 | – | Sell |
-6
| Closed | -$7 | – | 5026 |
|
|
2024
Q4 | $7 | Buy |
+6
| New | +$7 | ﹤0.01% | 4907 |
|
|
2024
Q3 | – | Sell |
-6,456
| Closed | -$6.46K | – | 4914 |
|
|
2024
Q2 | $6.46K | Sell |
6,456
-1,061
| -14% | -$1.06K | ﹤0.01% | 4469 |
|
|
2024
Q1 | $17.8K | Buy |
7,517
+1,780
| +31% | +$4.22K | ﹤0.01% | 4316 |
|
|
2023
Q4 | $12.9K | Buy |
5,737
+5,719
| +31,772% | +$12.9K | ﹤0.01% | 4371 |
|
|
2023
Q3 | $38 | Sell |
18
-29,451
| -100% | -$62.2K | ﹤0.01% | 4776 |
|
|
2023
Q2 | $91.1K | Sell |
29,469
-57,452
| -66% | -$178K | ﹤0.01% | 3624 |
|
|
2023
Q1 | $468K | Buy |
86,921
+45,383
| +109% | +$244K | ﹤0.01% | 2576 |
|
|
2022
Q4 | $276K | Buy |
41,538
+41,092
| +9,213% | +$273K | ﹤0.01% | 2887 |
|
|
2022
Q3 | $2K | Sell |
446
-313
| -41% | -$1.4K | ﹤0.01% | 4736 |
|
|
2022
Q2 | $4K | Sell |
759
-1,669
| -69% | -$8.8K | ﹤0.01% | 4941 |
|
|
2022
Q1 | $15K | Sell |
2,428
-4,215
| -63% | -$26K | ﹤0.01% | 4576 |
|
|
2021
Q4 | $77K | Buy |
6,643
+4,478
| +207% | +$51.9K | ﹤0.01% | 4100 |
|
|
2021
Q3 | $34K | Buy |
2,165
+1,623
| +299% | +$25.5K | ﹤0.01% | 4220 |
|
|
2021
Q2 | $10K | Sell |
542
-214
| -28% | -$3.95K | ﹤0.01% | 4997 |
|
|
2021
Q1 | $33K | Buy |
+756
| New | +$33K | ﹤0.01% | 4289 |
|